New shot form of cancer drug tested in advanced tumors
NCT ID NCT04606381
First seen Nov 01, 2025 · Last updated May 26, 2026 · Updated 29 times
Summary
This study tests a new way to give the cancer drug amivantamab as a shot under the skin instead of through an IV. It includes 158 adults with advanced solid tumors that may respond to this type of treatment. The main goals are to check safety and find the best dose for the shot form.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for NEOPLASMS are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Cedars Sinai Medical Center
West Hollywood, California, 90048, United States
-
Chungbuk National University Hospital
Cheongju-si, 28644, South Korea
-
Community Health Network
Indianapolis, Indiana, 46256, United States
-
Langone Health at NYC University, NYU School of Medicine
New York, New York, 10016, United States
-
Providence Portland Medical Center
Portland, Oregon, 97213, United States
-
Royal Marsden Hospital
Sutton, SM2 5PT, United Kingdom
-
Samsung Medical Center
Seoul, 06351, South Korea
-
Sarah Cannon Research Institute
Nashville, Tennessee, 37203, United States
-
Seoul National University Bundang Hospital
Seongnam-si, 13620, South Korea
-
Severance Hospital Yonsei University Health System
Seoul, 03722, South Korea
-
The Christie Nhs Foundation Trust
Manchester, M20 4BX, United Kingdom
-
University Health Network
Toronto, Ontario, M5G 2M9, Canada
Conditions
Explore the condition pages connected to this study.